Zydus Gets US Regulator’s Approval To Market Generic Epilepsy Drug
Topiramate capsules had annual sales of $68.8 million in the US. (Representational)New Delhi: Zydus Lifesciences today said it has received approval from the US health regulator to market Topiramate extended-release…